The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase I study of LOXO-292, a highly selective RET inhibitor, in pediatric patients with RET-altered cancers.
 
Steven G. DuBois
Honoraria - Loxo
Consulting or Advisory Role - Loxo
Research Funding - Curis (Inst); Lilly (Inst); Loxo (Inst); Merck (Inst); Millennium (Inst); Novartis (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Loxo; Roche/Genentech
 
Catherine Michelle Albert
No Relationships to Disclose
 
Leo Mascarenhas
Honoraria - Bayer
Consulting or Advisory Role - Bayer; Lilly (Inst)
Speakers' Bureau - Bayer
Research Funding - AstraZeneca/MedImmune (Inst)
Travel, Accommodations, Expenses - AstraZeneca/MedImmune; Bayer; Lilly
 
Theodore Willis Laetsch
Consulting or Advisory Role - Bayer; Lilly; Loxo; Novartis
Research Funding - Bayer (Inst); Loxo (Inst); Novartis (Inst); Pfizer (Inst)
 
Cornelis Martinus van Tilburg
Consulting or Advisory Role - Bayer; Novartis
 
Samara L Potter
No Relationships to Disclose
 
Brian Turpin
No Relationships to Disclose
 
Julia Lynne Glade Bender
Research Funding - Abbvie (Inst); Amgen (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Eisai (Inst); Ignyta (Inst); Lilly (Inst); Loxo (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Amgen; Merck; Novartis
 
Sheri L. Spunt
Research Funding - Loxo (Inst)
 
Raquel Hladun
No Relationships to Disclose
 
Michela Casanova
Consulting or Advisory Role - Bayer; Halozyme; Lilly; Merck; Roche; SERVIER; Tesaro
 
David Simon Ziegler
No Relationships to Disclose
 
Daniel A. Morgenstern
No Relationships to Disclose
 
Todd Eary
Employment - Loxo
Stock and Other Ownership Interests - Loxo
 
Shannon Ibabekci
Employment - Loxo
Stock and Other Ownership Interests - Loxo
 
Hope Qamoos
No Relationships to Disclose
 
Stephen M. Rothenberg
Employment - Loxo
Stock and Other Ownership Interests - Loxo
 
Michael Craig Cox
Employment - Amgen; Bayer; Loxo; Merck KGaA
Stock and Other Ownership Interests - Amgen; Bayer; Loxo; Merck KGaA
Patents, Royalties, Other Intellectual Property - US patent 62/318,041 issued to Loxo Oncology. (Inst)
 
Frank M. Balis
Research Funding - Epizyme (Inst); Loxo (Inst)
 
Alberto S. Pappo
Consulting or Advisory Role - Loxo/Bayer; Merck; ZIOPHARM Oncology